Piotr Adamski

9 Skłodowskiej Curie Street
Bydgoszcz, KP 85094, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Clopidogrel Versus Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome: New Insights from a Large Registry Compared to Randomized Clinical Trials-A Structured Review.

Clopidogrel Versus Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome: New Insights from a Large Registry Compared to Randomized Clinical Trials-A Structured Review.

Journal: Journal of clinical medicine

Published: March 21, 2026

Modulation of gut microFLORA with rifaximin to reduce high platelet reactivity in post-ACS patients on ticagrelor: rationale and design of the FLORA-ACS study.

Modulation of gut microFLORA with rifaximin to reduce high platelet reactivity in post-ACS patients on ticagrelor: rationale and design of the FLORA-ACS study.

Journal: Cardiology journal

Published: November 30, 2025

Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome.

Clinical outcomes and missed benefits related to clopidogrel overuse in acute coronary syndrome.

Journal: Journal of thrombosis and thrombolysis

Published: November 17, 2025

Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C.

Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C.

Journal: Journal of clinical medicine

Published: October 31, 2025

One-year clinical outcomes in patients with acute coronary syndrome treated with clopidogrel versus prasugrel versus ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS).

One-year clinical outcomes in patients with acute coronary syndrome treated with clopidogrel versus prasugrel versus ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS).

Journal: Kardiologia polska

Published: July 22, 2025

Lipid profile and the variables associated with control of selected lipid parameters in patients of a large multi-specialist hospital in Poland - the Jurasz Lipid Study (JLS).

Lipid profile and the variables associated with control of selected lipid parameters in patients of a large multi-specialist hospital in Poland - the Jurasz Lipid Study (JLS).

Journal: Lipids in health and disease

Published: April 26, 2025

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Journal: Cardiology journal

Published: February 13, 2025

Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.

Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.

Journal: International journal of cardiology

Published: April 06, 2024

Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Journal: Cardiology journal

Published: March 26, 2024

Platelet Reactivity in the Exacerbation of Psoriasis.

Platelet Reactivity in the Exacerbation of Psoriasis.

Journal: Journal of clinical medicine

Published: December 28, 2023

Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.

Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.

Journal: Cardiology journal

Published: November 27, 2023

Optimal antiplatelet therapy in patients with acute coronary syndromes - a still unfulfilled need?

Optimal antiplatelet therapy in patients with acute coronary syndromes - a still unfulfilled need?

Journal: Cardiology journal

Published: November 22, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026